LeMaitre Vascular Files 8-K Report
Ticker: LMAT · Form: 8-K · Filed: Dec 17, 2024 · CIK: 1158895
| Field | Detail |
|---|---|
| Company | Lemaitre Vascular Inc (LMAT) |
| Form Type | 8-K |
| Filed Date | Dec 17, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $150 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
LeMaitre Vascular filed a standard 8-K, no major news.
AI Summary
On December 16, 2024, LeMaitre Vascular, Inc. filed an 8-K report to disclose information under Regulation FD. The filing includes financial statements and exhibits, but no specific material events or financial figures were detailed in the provided text.
Why It Matters
This filing indicates that LeMaitre Vascular, Inc. is complying with regulatory reporting requirements, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report for regulatory compliance and does not disclose any new material information that would inherently increase risk.
Key Players & Entities
- LeMaitre Vascular, Inc. (company) — Registrant
- 001-33092 (company) — Commission File Number
- Delaware (company) — State of incorporation
- 04-2825458 (company) — IRS Employer Identification No.
- 63 Second Avenue Burlington, MA 01803 (company) — Principal executive offices address
- 781-221-2266 (company) — Registrant's telephone number
- December 16, 2024 (date) — Date of earliest event reported
FAQ
What is the purpose of this 8-K filing by LeMaitre Vascular, Inc.?
The 8-K filing is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, intended to report information under Regulation FD and include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on December 16, 2024.
What is LeMaitre Vascular, Inc.'s commission file number?
LeMaitre Vascular, Inc.'s commission file number is 001-33092.
Where are LeMaitre Vascular, Inc.'s principal executive offices located?
LeMaitre Vascular, Inc.'s principal executive offices are located at 63 Second Avenue, Burlington, MA 01803.
What is the standard industrial classification for LeMaitre Vascular, Inc.?
The standard industrial classification for LeMaitre Vascular, Inc. is SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841].
Filing Stats: 501 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-12-17 06:31:17
Key Financial Figures
- $150 million — cing that it had priced its offering of $150 million aggregate principal amount of 2.50% Con
Filing Documents
- tm2430433d3_8k.htm (8-K) — 25KB
- tm2430433d3_ex99-1.htm (EX-99.1) — 11KB
- tm2430433d3_ex99-1img01.jpg (GRAPHIC) — 4KB
- 0001104659-24-129159.txt ( ) — 214KB
- lmat-20241216.xsd (EX-101.SCH) — 3KB
- lmat-20241216_lab.xml (EX-101.LAB) — 33KB
- lmat-20241216_pre.xml (EX-101.PRE) — 22KB
- tm2430433d3_8k_htm.xml (XML) — 4KB
01
Item 7.01 Regulation FD Disclosure. On December 16, 2024, LeMaitre Vascular, Inc. (the "Company") issued a press release announcing that it had priced its offering of $150 million aggregate principal amount of 2.50% Convertible Senior Notes due 2030 (the "Notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. A copy of the press release is furnished as Exhibit 99.1 and incorporated herein by reference. Neither this Current Report on Form 8-K nor the press release constitutes an offer to sell, or the solicitation of an offer to buy, the Notes or the shares of the Company's common stock, if any, issuable upon conversion of the Notes.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release of LeMaitre Vascular, Inc. dated December 16, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LeMaitre Vascular, Inc. Date: December 16, 2024 By: /s/ Joseph P. Pellegrino, Jr. Name: Joseph P. Pellegrino, Jr. Title: Chief Financial Officer